In 1984 the FDA passed the Orphan Drug Act1 in an effort to push the industry to pursue the treatment of rare diseases that afflict less than 200,000 patients a year in the U.S. Under the original Orphan Drug Act, companies were eligible for several extra years of marketing exclusivity, without generic competition, if they were able…
New Drug Launched in the U.S. to Help Treat Opioid Use Disorder
Walgreens to Pay Feds and States $60m in Largest-Ever Settlement by a Pharmacy Chain for Overcharging for Drugs
Advanced Studies and Latest Innovation Helping Hemp/CBD Companies Increase Yields
The Future of FDA’s Electronic Safety Surveillance
Opioids Fueled a Doubling of Suicides and Overdoses in the U.S.
Legal Marijuana Industry Toasts Year of Global Gains
PORTLAND, Ore. (AP) — The last year was a 12-month champagne toast for the legal marijuana industry as the global market exploded and cannabis pushed its way further into the financial and cultural mainstream. Liberal California became the largest legal U.S. marketplace, while conservative Utah and Oklahoma embraced medical marijuana. Canada ushered in broad legalization,…
Thailand Legislature Legalizes Medical Marijuana and Kratom
BANGKOK (AP) — Thailand’s legislature on Tuesday agreed to amend the country’s drug law to allow the licensed medical use of marijuana, as well as kratom, a locally grown plant traditionally used as a stimulant and painkiller. Thailand is the first country in Southeast Asia to take such action, which is also under consideration in…
Updated Lawsuit Teases New Details Against OxyContin Maker
U.S. Urges Doctors to Write More Rx for Overdose Antidote
The U.S. government told doctors Wednesday to consider prescribing medications that reverse overdoses to many more patients who take opioid painkillers in a move that could add more than $1 billion in health care costs. Assistant Secretary for Health Brett Giroir, a doctor appointed by President Donald Trump, announced the guidance, saying it’s important for…